Nevertheless, a recent study reported a contrary effect that the cytotoxicity of PARP inhibitors was dramatically enhanced by mTOR inhibitors in BRCA-proficient triple-negative breast cancers in vitro and in vivo, at the same time revealing a novel mechanism for mTOR signaling to regulate the homologous recombination process (39). Here, MTOR is linked to triple-negative breast carcinoma.